Clinical Trial Update: Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AMG0001 evaluating improvement in ulcer healing and perfusion in subjects with peripheral ischemic ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease
• Ischemic Ulcer of Foot
• Limb-threatening Ischemia
• Peripheral Artery Disease

Drugs mentioned

• AMG0001

Snippet

Sponsor: AnGes USA, Inc. | Conditions: Peripheral Artery Disease, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease | Phase 2 | Status: UNKNOWN